Pivotal bioVenture Partners
Investor profile
Venture capital
Pivotal bioVenture Partners has backed 2 European tech companies across 2 funding rounds between 2021 and 2025, joining rounds totalling €117M. Most active in Healthtech. Data as of Nov 2026.
Deals
2
distinct rounds
Companies
2
backed
Active span
2021–2025
5 yrs
Total round €
€117M
sum of rounds joined
Deals by year
distinct rounds / yearPivotal bioVenture Partners — deals by year — interactive chart.
Data table
| Pivotal bioVenture Partners — deals by year | |
|---|---|
| 2021 | 1 |
| 2025 | 1 |
Top sectors
by dealsPivotal bioVenture Partners — top sectors — interactive chart.
Data table
| Pivotal bioVenture Partners — top sectors | |
|---|---|
| Healthtech | 2 |
Stages
by dealsPivotal bioVenture Partners — stages — interactive chart.
Data table
| Pivotal bioVenture Partners — stages | |
|---|---|
| Series A | 1 |
| Series C | 1 |
Countries
by dealsPivotal bioVenture Partners — countries — interactive chart.
Data table
| Pivotal bioVenture Partners — countries | |
|---|---|
| Switzerland | 2 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared roundsPortfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Mosanna Therapeutics | Switzerland | 1 | €70M |
| Oculis | Switzerland | 1 | €47M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Mosanna Therapeutics | Series A | €70M | 2025-06 |
| Oculis | Series C | €47M | 2021-05 |